{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:01:39Z","timestamp":1787457699104,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejca.2015.06.109","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T20:45:12Z","timestamp":1440017112000},"page":"2413-2422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas"],"prefix":"10.1016","volume":"51","author":[{"given":"Mrinal","family":"Gounder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Kuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan","family":"Agaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arcila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Keohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra P.","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerav","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Noy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Adrianzen","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pourmoussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.06.109_b0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.ejca.2015.06.109_b0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/COC.0b013e31824be22b","article-title":"Interdigitating and follicular dendritic cell sarcomas: a SEER analysis","volume":"36","author":"Perkins","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.06.109_b0015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","article-title":"Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy","volume":"28","author":"Hornick","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2015.06.109_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ejca.2015.06.109_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2015.06.109_b0030","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000478-200205000-00013","article-title":"Hyaline vascular Castleman\u2019s disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis","volume":"26","author":"Cokelaere","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2015.06.109_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000340066","article-title":"Histiocytic sarcoma \u2013 targeted therapy: novel therapeutic options? A series of 4 cases","volume":"35","author":"Schlick","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.ejca.2015.06.109_b0045","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/cncr.26712","article-title":"Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab","volume":"118","author":"Shukla","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.06.109_b0050","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/cancers6042275","article-title":"Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years","volume":"6","author":"Dalia","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2015.06.109_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi","year":"2013","journal-title":"J Clin Exp Hematopathol"},{"key":"10.1016\/j.ejca.2015.06.109_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.critrevonc.2013.05.006","article-title":"Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series","volume":"88","author":"Saygin","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2015.06.109_b0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0046-8177(03)00356-3","article-title":"Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman\u2019s disease","volume":"34","author":"Sun","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2015.06.109_b0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bjc.6604965","article-title":"Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes","volume":"100","author":"Alfaro","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.06.109_b0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/annonc\/mds602","article-title":"Phase I\/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma","volume":"24","author":"Mita","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.06.109_b0080","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/leu.2014.167","article-title":"Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor","volume":"28","author":"Brunner","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2015.06.109_b0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.5858\/arpa.2012-0104-RS","article-title":"Histiocytic\/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies","volume":"137","author":"Stoecker","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2015.06.109_b0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/PAS.0b013e31820ca624","volume":"35","author":"Wang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2015.06.109_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pbc.22810","article-title":"Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A","volume":"56","author":"Kumar","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2015.06.109_b0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2006.03.028","article-title":"The PTEN and INK4A\/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2015.06.109_b0105","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejca.2015.06.109_b0115","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0120","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0125","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim\u2013Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0130","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.06.109_b0135","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720","article-title":"Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab","volume":"100","author":"Buggins","year":"2002","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T10:11:19Z","timestamp":1599473479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0959804915006243"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.109","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.06.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}